JPWO2023204291A5 - - Google Patents

Info

Publication number
JPWO2023204291A5
JPWO2023204291A5 JP2024516324A JP2024516324A JPWO2023204291A5 JP WO2023204291 A5 JPWO2023204291 A5 JP WO2023204291A5 JP 2024516324 A JP2024516324 A JP 2024516324A JP 2024516324 A JP2024516324 A JP 2024516324A JP WO2023204291 A5 JPWO2023204291 A5 JP WO2023204291A5
Authority
JP
Japan
Prior art keywords
group
substituted
halogen atoms
alkoxy
different halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024516324A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023204291A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/015863 external-priority patent/WO2023204291A1/ja
Publication of JPWO2023204291A1 publication Critical patent/JPWO2023204291A1/ja
Publication of JPWO2023204291A5 publication Critical patent/JPWO2023204291A5/ja
Pending legal-status Critical Current

Links

JP2024516324A 2022-04-22 2023-04-21 Pending JPWO2023204291A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022071112 2022-04-22
PCT/JP2023/015863 WO2023204291A1 (ja) 2022-04-22 2023-04-21 ビシクロアミンカルボキサミド誘導体

Publications (2)

Publication Number Publication Date
JPWO2023204291A1 JPWO2023204291A1 (cg-RX-API-DMAC7.html) 2023-10-26
JPWO2023204291A5 true JPWO2023204291A5 (cg-RX-API-DMAC7.html) 2026-04-27

Family

ID=88419943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024516324A Pending JPWO2023204291A1 (cg-RX-API-DMAC7.html) 2022-04-22 2023-04-21

Country Status (9)

Country Link
EP (1) EP4512807A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023204291A1 (cg-RX-API-DMAC7.html)
CN (1) CN119053606A (cg-RX-API-DMAC7.html)
AU (1) AU2023256391A1 (cg-RX-API-DMAC7.html)
CA (1) CA3248959A1 (cg-RX-API-DMAC7.html)
IL (1) IL316360A (cg-RX-API-DMAC7.html)
MX (1) MX2024012992A (cg-RX-API-DMAC7.html)
TW (1) TW202404962A (cg-RX-API-DMAC7.html)
WO (1) WO2023204291A1 (cg-RX-API-DMAC7.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009506061A (ja) * 2005-08-26 2009-02-12 メルク エンド カムパニー インコーポレーテッド ジアザスピロデカンオレキシン受容体拮抗薬
SG11201806429PA (en) 2016-02-04 2018-08-30 Takeda Pharmaceuticals Co Substituted piperidine compound and use thereof
PE20221730A1 (es) 2019-11-27 2022-11-07 Sumitomo Pharma Co Ltd Derivado de cicloalquilurea
JPWO2022250108A1 (cg-RX-API-DMAC7.html) * 2021-05-26 2022-12-01

Similar Documents

Publication Publication Date Title
JP7739180B2 (ja) シクロアルキルウレア誘導体
CN103842332B (zh) 环丙胺化合物
JP6599983B2 (ja) カルバゾール誘導体
JPWO2022250108A5 (cg-RX-API-DMAC7.html)
EA010887B1 (ru) Тетрагидроиндазольные модуляторы каннабиноидов
EP3331876A1 (en) Modulators of ror-gamma
CN101686952A (zh) 新型钙离子通道调节剂
JPWO2010058846A1 (ja) 4,6−ジアミノニコチンアミド化合物
JP2012532152A (ja) Jak受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物
CN102388034A (zh) 杂环化合物及其作为糖原合酶激酶-3抑制剂的用途
JP6592512B2 (ja) 三環式アトロプ異性体の化合物
WO2022250108A1 (ja) フェニルウレア誘導体
JP2020520925A (ja) 化合物、組成物および方法
TW202204344A (zh) 酪胺酸激酶2抑制劑、其製備方法及醫藥用途
CN111801100A (zh) 用于治疗和预防肝癌的7-取代的磺亚氨酰基嘌呤酮化合物和衍生物
CN103038218A (zh) 稠环吡啶化合物
KR20250164848A (ko) Kcc2 강화제 및 이의 용도
MX2010011663A (es) Derivados de 1-(7-hexahidropirrolo [3,4-c] pirrol-2 (1h)-il) quinolin-3-il)-(pirazin-2-il) urea y compuestos relacionados como glicogeno sintasa quinasa 3 (gsk-3).
US20230257390A1 (en) Compounds which inhibit rna polymerase and their use
WO2008032764A1 (en) Fused heterocyclic derivative
JP2022183120A5 (cg-RX-API-DMAC7.html)
RU2024134350A (ru) Бициклоаминкарбоксамидное производное
TW201930311A (zh) 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑
JP7668768B2 (ja) シクロアルキルウレア誘導体を含有する医薬組成物
WO2006082975A1 (ja) 光学活性なテトラヒドロナフタレン誘導体